The state of Maryland and Bloomberg Philanthropies are jointly funding a Johns Hopkins-led study to develop a possible treatment for COVID-19 using blood plasma from survivors of the virus, Gov. Larry Hogan’s office announced today.
Arturo Casadevall, an infectious disease expert at both the Johns Hopkins University Bloomberg School of Public Health and the Johns Hopkins School of Medicine, will lead a team of researchers. Their hope is that isolating plasma from survivors could treat people infected with the virus and boost the immune systems of doctors and first responders.
“Casadevall and his team believe that using plasma from recovered viral positive patients could provide immediate immunity to the most at-risk individuals,” Hogan’s office said in the release. “The strategy of isolating plasma is a long-established technology, and recent advances make it as safe as a blood transfusion.”
READ FULL ARTICLE HERE
